SCHEMBL25752966

SCHEMBL25752966

c1ccc(-c2cccc([Si](c3cccc(-c4ccccc4)c3)(c3cccc(-c4ccccc4)c3)c3cccc(-c4cc(-c5cccc(-n6c7ccccc7c7ccccc76)c5)nc(-n5c6ccccc6c6cc(-c7ccccc7)ccc65)n4)c3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
TSPO P30536 1/20 0.33
PTGER4 P35408 1/20 0.32
PTGES O14684 1/20 0.32
PDE10A Q9Y233 1/20 0.32
NPY5R Q15761 1/20 0.32
TET2 Q6N021 1/20 0.31
TET1 Q8NFU7 1/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
TUBB4A P04350 1/20 0.30
TUBB P07437 1/20 0.30
TUBA3C P0DPH7 1/20 0.30
TUBA1B P68363 1/20 0.30
TUBA4A P68366 1/20 0.30
TUBB4B P68371 1/20 0.30
TUBB3 Q13509 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25752962 0.99 KDM4E (0.36) L3MBTL1KDM4EATMTSPOPTGER4
SCHEMBL25752933 0.95 KDM4E (0.41) L3MBTL1KDM4EATMPDE10ATET2
SCHEMBL25752930 0.94 KDM4E (0.40) L3MBTL1KDM4EATMPDE10ATET2
SCHEMBL25752931 0.94 KDM4E (0.40) L3MBTL1KDM4EATMPDE10ATET2
SCHEMBL25752952 0.93 TSPO (0.36) L3MBTL1KDM4ETSPOPTGESNPY5R
SCHEMBL25752948 0.92 TSPO (0.35) L3MBTL1KDM4ETSPOPTGESNPY5R
SCHEMBL25752949 0.92 TSPO (0.35) L3MBTL1KDM4ETSPOPTGESNPY5R
SCHEMBL26375943 0.91 KDM4E (0.34) L3MBTL1KDM4EATMPTGESMEN1
SCHEMBL26375940 0.91 KDM4E (0.34) L3MBTL1KDM4EATM
SCHEMBL18213908 0.91 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPOPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217807-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed
US-20230217807-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217807-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CYP1A1, CYP1B1 L3MBTL1 992/4885KDM4E 2724/4885ATM 3848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.